CSTL News and Press, Castle Biosciences Inc. From 05/05/25

2025-05-05 22:58:07 ET Castle Biosciences, Inc. (CSTL) Q1 2025 Earnings Conference Call May 5, 2025 16:30 ET Company Participants Camilla Zuckero - Vice President of Investor Relations and Corporate Affairs Derek Maetzold - Founder, President & Chief Executive Of...

2025-05-05 16:46:44 ET More on Castle Biosciences Castle Biosciences: Steady Revenue Stream, But Medicare Reimbursement Loss A Concern Castle Biosciences, Inc. (CSTL) Q4 2024 Earnings Call Transcript Castle Biosciences, Inc. 2024 Q4 - Results - Earnings Call Presenta...

2025-05-05 16:27:53 ET More on Castle Biosciences Castle Biosciences: Steady Revenue Stream, But Medicare Reimbursement Loss A Concern Castle Biosciences, Inc. (CSTL) Q4 2024 Earnings Call Transcript Castle Biosciences, Inc. 2024 Q4 - Results - Earnings Call Presenta...

Q 1 2025 revenue increased 21% over Q 1 2024 to $88 million Q 1 2025 total test reports for our core revenue drivers (DecisionDx ® -Melanoma, DecisionDx ® -SCC, TissueCypher ® ) increased 33% ov...

Expected to complement Castle’s current gastroenterology franchise Adds methylation technology developed at the Johns Hopkins University School of Medicine and additional technologies in development FRIENDSWOOD, Texas, May 05, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc....

National Health Investors Inc. (NHI) is expected to report $1.13 for Q1 2025 Palomar Holdings Inc. (PLMR) is expected to report $1.45 for Q1 2025 Weave Communications Inc. (WEAV) is expected to report $-0.11 for Q1 2025 First National Bank Alaska (FBAK) is expected to report for Q1 20...

2025-05-04 18:48:27 ET Castle Biosciences, Inc. (CSTL) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 4.87%. The average open to low on the day of earnings was -10.17%. The average open...

2025-05-04 18:43:27 ET Castle Biosciences, Inc. (CSTL) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in CSTL stock price following earnings has averaged ±6.50% , with a median of 4.48%....

2025-05-02 17:35:44 ET More on Castle Biosciences Castle Biosciences: Steady Revenue Stream, But Medicare Reimbursement Loss A Concern Castle Biosciences, Inc. (CSTL) Q4 2024 Earnings Call Transcript Castle Biosciences, Inc. 2024 Q4 - Results - Earnings Call Presenta...

Additionally, an expert physician panel convened by EndoscopyNow will host a product theater on Sunday, May 4, at 2:45 p.m. Pacific Time, titled, “The Time is Now: A Clinical Practice Model to Help Prevent Progression from Barrett's to EAC” FRIENDSWOOD, Texas, May 02, 2025 (GL...